Development of a hand-held device to assess radiation exposure in emergencies
Research and Development of a Hand-held, Rapid, Point-of-Care Radiation Biodosimetry Triage Device and Integration of Soluble and Cell-surface Radiation Injury Biomarker Assays
This study is testing a handy device called CellRADx that helps doctors quickly check if someone has been exposed to radiation during emergencies, like a nuclear accident, so they can give the right care right away.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Asell, LLC NIH-funded |
| Lab location | 1 site (Owings Mills, United States) |
| Project ID | NIH-11116405 on NIH RePORTER |
What this research studies
This research focuses on creating a portable device called CellRADx that can quickly assess radiation exposure in patients during emergencies, such as nuclear incidents. It combines a Complete Blood Count (CBC) with the detection of specific biomarkers related to radiation injury. The device aims to provide immediate results to help healthcare providers triage patients effectively. The research also involves improving the algorithms used for dose determination based on feedback from regulatory agencies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may be exposed to radiation in mass casualty events, such as first responders or civilians in affected areas.
Not a fit: Patients who are not at risk of radiation exposure or those with pre-existing conditions that complicate blood analysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enable rapid and accurate assessment of radiation exposure, improving patient outcomes in emergency situations.
How similar studies have performed: Similar research has shown promise in developing biodosimetry devices, indicating potential for success in this innovative approach.
Where this research is happening
Owings Mills, United States
- Asell, LLC — Owings Mills, United States (Active)
Researchers
- Principal investigator: Kowalski, Richard Joseph — Asell, LLC
- Study coordinator: Kowalski, Richard Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.